LONP1 and cancer: Thus, we wondered whether treating different human cell lines, such as RKO, HepG2 and MCF7, compared to normal fibroblasts, with compounds that could have a potential interest for cancer treatment, i.e. CDDO or its methyl ester derivative, would provide the same effects found by shRNA knockdown of Lon.